1250 related articles for article (PubMed ID: 17101639)
1. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
Lee JK; Grace KA; Taylor AJ
JAMA; 2006 Dec; 296(21):2563-71. PubMed ID: 17101639
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted intervention to improve medication adherence and secondary prevention measures after acute coronary syndrome hospital discharge: a randomized clinical trial.
Ho PM; Lambert-Kerzner A; Carey EP; Fahdi IE; Bryson CL; Melnyk SD; Bosworth HB; Radcliff T; Davis R; Mun H; Weaver J; Barnett C; Barón A; Del Giacco EJ
JAMA Intern Med; 2014 Feb; 174(2):186-93. PubMed ID: 24247275
[TBL] [Abstract][Full Text] [Related]
3. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.
Thom S; Poulter N; Field J; Patel A; Prabhakaran D; Stanton A; Grobbee DE; Bots ML; Reddy KS; Cidambi R; Bompoint S; Billot L; Rodgers A;
JAMA; 2013 Sep; 310(9):918-29. PubMed ID: 24002278
[TBL] [Abstract][Full Text] [Related]
4. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.
Selak V; Elley CR; Bullen C; Crengle S; Wadham A; Rafter N; Parag V; Harwood M; Doughty RN; Arroll B; Milne RJ; Bramley D; Bryant L; Jackson R; Rodgers A
BMJ; 2014 May; 348():g3318. PubMed ID: 24868083
[TBL] [Abstract][Full Text] [Related]
5. A multimodal blood pressure control intervention in 3 healthcare systems.
Magid DJ; Ho PM; Olson KL; Brand DW; Welch LK; Snow KE; Lambert-Kerzner AC; Plomondon ME; Havranek EP
Am J Manag Care; 2011 Apr; 17(4):e96-103. PubMed ID: 21774100
[TBL] [Abstract][Full Text] [Related]
6. Nurse-Led, Telephone-Based, Secondary Preventive Follow-Up after Stroke or Transient Ischemic Attack Improves Blood Pressure and LDL Cholesterol: Results from the First 12 Months of the Randomized, Controlled NAILED Stroke Risk Factor Trial.
Irewall AL; Ögren J; Bergström L; Laurell K; Söderström L; Mooe T
PLoS One; 2015; 10(10):e0139997. PubMed ID: 26474055
[TBL] [Abstract][Full Text] [Related]
7. Effect of a Coordinated Community and Chronic Care Model Team Intervention vs Usual Care on Systolic Blood Pressure in Patients With Stroke or Transient Ischemic Attack: The SUCCEED Randomized Clinical Trial.
Towfighi A; Cheng EM; Ayala-Rivera M; Barry F; McCreath H; Ganz DA; Lee ML; Sanossian N; Mehta B; Dutta T; Razmara A; Bryg R; Song SS; Willis P; Wu S; Ramirez M; Richards A; Jackson N; Wacksman J; Mittman B; Tran J; Johnson RR; Ediss C; Sivers-Teixeira T; Shaby B; Montoya AL; Corrales M; Mojarro-Huang E; Castro M; Gomez P; Muñoz C; Garcia D; Moreno L; Fernandez M; Lopez E; Valdez S; Haber HR; Hill VA; Rao NM; Martinez B; Hudson L; Valle NP; Vickrey BG;
JAMA Netw Open; 2021 Feb; 4(2):e2036227. PubMed ID: 33587132
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial.
Frias J; Virdi N; Raja P; Kim Y; Savage G; Osterberg L
J Med Internet Res; 2017 Jul; 19(7):e246. PubMed ID: 28698169
[TBL] [Abstract][Full Text] [Related]
9. Long-term, telephone-based follow-up after stroke and TIA improves risk factors: 36-month results from the randomized controlled NAILED stroke risk factor trial.
Ögren J; Irewall AL; Söderström L; Mooe T
BMC Neurol; 2018 Sep; 18(1):153. PubMed ID: 30241499
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial.
He J; Irazola V; Mills KT; Poggio R; Beratarrechea A; Dolan J; Chen CS; Gibbons L; Krousel-Wood M; Bazzano LA; Nejamis A; Gulayin P; Santero M; Augustovski F; Chen J; Rubinstein A;
JAMA; 2017 Sep; 318(11):1016-1025. PubMed ID: 28975305
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
[TBL] [Abstract][Full Text] [Related]
12. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
Choudhry NK; Isaac T; Lauffenburger JC; Gopalakrishnan C; Lee M; Vachon A; Iliadis TL; Hollands W; Elman S; Kraft JM; Naseem S; Doheny S; Lee J; Barberio J; Patel L; Khan NF; Gagne JJ; Jackevicius CA; Fischer MA; Solomon DH; Sequist TD
JAMA Intern Med; 2018 Sep; 178(9):1182-1189. PubMed ID: 30083727
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an outpatient pharmacy clinical services program on adherence and clinical outcomes among patients with diabetes and/or coronary artery disease.
Spence MM; Makarem AF; Reyes SL; Rosa LL; Nguyen C; Oyekan EA; Kiyohara AT
J Manag Care Spec Pharm; 2014 Oct; 20(10):1036-45. PubMed ID: 25278326
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.
Murray MD; Young J; Hoke S; Tu W; Weiner M; Morrow D; Stroupe KT; Wu J; Clark D; Smith F; Gradus-Pizlo I; Weinberger M; Brater DC
Ann Intern Med; 2007 May; 146(10):714-25. PubMed ID: 17502632
[TBL] [Abstract][Full Text] [Related]
16. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
Korcegez EI; Sancar M; Demirkan K
J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
[TBL] [Abstract][Full Text] [Related]
17. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.
Hirsch JD; Steers N; Adler DS; Kuo GM; Morello CM; Lang M; Singh RF; Wood Y; Kaplan RM; Mangione CM
Clin Ther; 2014 Sep; 36(9):1244-54. PubMed ID: 25085406
[TBL] [Abstract][Full Text] [Related]
18. A cluster randomized controlled Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia: the TEAM study.
Villeneuve J; Genest J; Blais L; Vanier MC; Lamarre D; Fredette M; Lussier MT; Perreault S; Hudon E; Berbiche D; Lalonde L
CMAJ; 2010 Mar; 182(5):447-55. PubMed ID: 20212029
[TBL] [Abstract][Full Text] [Related]
19. Randomized Controlled Trial of E-Counseling for Hypertension: REACH.
Nolan RP; Feldman R; Dawes M; Kaczorowski J; Lynn H; Barr SI; MacPhail C; Thomas S; Goodman J; Eysenbach G; Liu S; Tanaka R; Surikova J
Circ Cardiovasc Qual Outcomes; 2018 Jul; 11(7):e004420. PubMed ID: 30006474
[TBL] [Abstract][Full Text] [Related]
20. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial).
Stewart K; George J; Mc Namara KP; Jackson SL; Peterson GM; Bereznicki LR; Gee PR; Hughes JD; Bailey MJ; Hsueh YA; McDowell JM; Bortoletto DA; Lau R
J Clin Pharm Ther; 2014 Oct; 39(5):527-34. PubMed ID: 24943987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
